Unlike Delta variant, Omicron less likely to cause long Covid: Lancet study

The Omicron variant of the SARS-CoV-2 virus is less likely to cause long COVID than the Delta strain, according to a study published in The Lancet journal.

coronavirus
Photo by Viktor Forgacs on Unsplash
Press Trust of India London
2 min read Last Updated : Jun 21 2022 | 1:19 PM IST

The Omicron variant of the SARS-CoV-2 virus is less likely to cause long COVID than the Delta strain, according to a study published in The Lancet journal.

Long COVID is defined as having new or ongoing symptoms four weeks or more after the start of the disease, the researchers said.

Symptoms include fatigue, shortness of breath, loss of concentration, and joint pain, which can adversely affect day-to-day activities, and in some cases can be severely limiting, they said.

The researchers found that the odds of experiencing long COVID were between 20-50 per cent less during the Omicron period versus the Delta period, depending on age and time since vaccination.

"The Omicron variant appears substantially less likely to cause Long-COVID than previous variants but still 1 in 23 people who catch COVID-19 go on to have symptoms for more than four weeks," said study lead author Claire Steves from King's College London, UK.

The study identified 56,003 UK adult cases first testing positive between December 20, 2021, and March 9, 2022, when Omicron was the dominant strain.

Researchers compared these cases to 41,361 cases first testing positive between June 1, 2021, and November 27, 2021, when the Delta variant was dominant.

The analysis shows 4.4 per cent of Omicron cases were long COVID, compared to 10.8 per cent of Delta cases.

However, the absolute number of people experiencing long COVID was in fact higher in the Omicron period, the researchers said.

This was because of the vast number of people infected with Omicron from December 2021 to February 2022, they said.

The UK Office of National Statistics estimated the number of people with long COVID actually increased from 1.3 million in January 2022 to 2 million as of May 1, 2022.

"Given the numbers of people affected it is important that we continue to support them at work, at home and within the NHS," Steves added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusLancet reportDelta

First Published: Jun 21 2022 | 1:19 PM IST

Next Story